Search research articles
Contact Us
Filters
Showing results (11-20 of 299) with videos related to
Page
of 30
Sort By:
Current Opinion in Pharmacology
|
July 20, 2002
Using genetic variation to study immunomodulation
Stephen Chanock, James G Taylor
The Journal of Infectious Diseases
|
November 4, 2006
Genetic association studies: marking them well
Nick Orr, Vincent Bekker, Stephen Chanock
Clinical Microbiology Reviews
|
October 17, 2006
Human pharmacogenomic variations and their implications for antifungal efficacy
Joseph Meletiadis, Stephen Chanock, Thomas J Walsh
Human Heredity
|
December 17, 2008
Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry
Vincent Bekker, Thomas R O'Brien, Stephen Chanock
Pharmacogenomics
|
May 10, 2008
Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents
Joseph Meletiadis, Stephen Chanock, Thomas J Walsh
Infectious Disease Clinics of North America
|
May 20, 2003
Immunomodulation of invasive fungal infections
Emmanuel Roilides, Caron A Lyman, Paraskevi Panagopoulou, et al.
Genetic Epidemiology
|
March 4, 2011
Efficient study design for next generation sequencing
Joshua Sampson, Kevin Jacobs, Meredith Yeager, et al.
IARC Scientific Publications
|
April 2, 2004
Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies
Anneclaire J De Roos, Martyn T Smith, Stephen Chanock, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 17, 2009
Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility
H Dean Hosgood, Richard Cawthon, Xingzhou He, et al.
Genetic Epidemiology
|
July 8, 2009
Methods for detecting interactions between genetic polymorphisms and prenatal environment exposure with a mother-child design
Shuang Wang, Tian Zheng, Stephen Chanock, et al.
Page
of 30
Search research articles
Search
Showing results (11-20 of 299) with videos related to
Sort By:
Page
of 30
Current Opinion in Pharmacology
|
July 20, 2002
Using genetic variation to study immunomodulation
Stephen Chanock, James G Taylor
The Journal of Infectious Diseases
|
November 4, 2006
Genetic association studies: marking them well
Nick Orr, Vincent Bekker, Stephen Chanock
Clinical Microbiology Reviews
|
October 17, 2006
Human pharmacogenomic variations and their implications for antifungal efficacy
Joseph Meletiadis, Stephen Chanock, Thomas J Walsh
Human Heredity
|
December 17, 2008
Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry
Vincent Bekker, Thomas R O'Brien, Stephen Chanock
Pharmacogenomics
|
May 10, 2008
Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents
Joseph Meletiadis, Stephen Chanock, Thomas J Walsh
Infectious Disease Clinics of North America
|
May 20, 2003
Immunomodulation of invasive fungal infections
Emmanuel Roilides, Caron A Lyman, Paraskevi Panagopoulou, et al.
Genetic Epidemiology
|
March 4, 2011
Efficient study design for next generation sequencing
Joshua Sampson, Kevin Jacobs, Meredith Yeager, et al.
IARC Scientific Publications
|
April 2, 2004
Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies
Anneclaire J De Roos, Martyn T Smith, Stephen Chanock, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 17, 2009
Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility
H Dean Hosgood, Richard Cawthon, Xingzhou He, et al.
Genetic Epidemiology
|
July 8, 2009
Methods for detecting interactions between genetic polymorphisms and prenatal environment exposure with a mother-child design
Shuang Wang, Tian Zheng, Stephen Chanock, et al.
Page
of 30